Waypoint Capital Advisors, LLC Revance Therapeutics, Inc. Transaction History

Waypoint Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	BUY	$18.36 - $35.27 $679,320 - $1.3 Million	37,000 Added 68.53%	90,989 $2.93 Million
Q4 2022 Jan 23, 2023	BUY	$18.32 - $30.66 $989,078 - $1.66 Million	53,989 New	53,989 $0
Q2 2022 Jul 18, 2022	SELL	$11.52 - $20.4 $621,953 - $1.1 Million	-53,989 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$12.36 - $20.31 $667,304 - $1.1 Million	53,989 New	53,989 $1.02 Million

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Waypoint Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Waypoint Capital Advisors, LLC with notifications on news.